RJ
Raymond James Latest Price Targets & Analyst Ratings
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Consumer Discretionary
Consumer Staples
Energy
Financials
Healthcare
Industrials
Materials
Real Estate
Technology
Utilities
Communication Services
Advertising Agencies
Broadcasting
Electronic Gaming & Multimedia
Entertainment
Internet Content & Information
Publishing
Telecom Services
Consumer Discretionary
Apparel Manufacturing
Apparel Retail
Auto Manufacturers
Auto Parts
Auto & Truck Dealerships
Department Stores
Footwear & Accessories
Furnishings, Fixtures & Appliances
Gambling
Home Improvement Retail
Internet Retail
Leisure
Lodging
Luxury Goods
Packaging & Containers
Personal Services
Recreational Vehicles
Residential Construction
Resorts & Casinos
Restaurants
Specialty Retail
Textile Manufacturing
Travel Services
Consumer Staples
Beverages - Brewers
Beverages - Non-Alcoholic
Beverages - Wineries & Distilleries
Confectioners
Discount Stores
Education & Training Services
Farm Products
Food Distribution
Grocery Stores
Household & Personal Products
Packaged Foods
Tobacco
Energy
Oil & Gas Drilling
Oil & Gas Equipment & Services
Oil & Gas Exploration & Production
Oil & Gas Integrated
Oil & Gas Midstream
Oil & Gas Refining & Marketing
Thermal Coal
Uranium
Financials
Asset Management
Banks - Diversified
Banks - Regional
Capital Markets
Credit Services
Diversified Insurance
Financial Conglomerates
Financial Data & Stock Exchanges
Insurance Brokers
Life Insurance
Mortgage Finance
Property & Casualty Insurance
Reinsurance
Shell Companies
Specialty - Insurance
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
Health Information Services
Medical Care Facilities
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Industrials
Aerospace & Defense
Airlines
Airports & Air Services
Building Products & Equipment
Business Equipment & Supplies
Conglomerates
Consulting Services
Electrical Equipment & Parts
Engineering & Construction
Farm & Heavy Construction Machinery
Industrial Distribution
Infrastructure Operations
Integrated Freight & Logistics
Marine Shipping
Metal Fabrication
Pollution & Treatment Controls
Railroads
Rental & Leasing Services
Security & Protection Services
Specialty Business Services
Specialty Industrial Machinery
Staffing & Employment Services
Tools & Accessories
Trucking
Waste Management
Materials
Agricultural Inputs
Aluminum
Building Materials
Chemicals
Coking Coal
Copper
Gold
Lumber & Wood Production
Other Industrial Metals & Mining
Other Precious Metals & Mining
Paper & Paper Products
Silver
Specialty Chemicals
Steel
Real Estate
Diversified REIT
Healthcare Facilities REIT
Hotel & Motel REIT
Industrial REIT
Mortgage REIT
Office REIT
Real Estate Development
Real Estate Diversified
Real Estate Services
Residential REIT
Retail REIT
Specialty REIT
Technology
Communication Equipment
Computer Hardware
Consumer Electronics
Electronic Components
Electronics & Computer Distribution
Information Technology Services
Scientific & Technical Instruments
Semiconductor Equipment & Materials
Semiconductors
Software - Application
Software - Infrastructure
Solar
Utilities
Diversified Utilities
Electric Utilities
Gas Utilities
Independent Power Producers
Renewable Electricity
Water Utilities
Positive
Neutral
Negative
7 Days
1 Month
3 Months
6 Months
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
501 |
501
Arrow Electronics
ARW
$6.54B
|
MF
Melissa Fairbanks
| $127.06 | $135 |
6%
upside
| Outperform |
1 Nov ‘24
10 months ago |
|
502 |
502
Alnylam Pharmaceuticals
ALNY
$61.5B
|
GN
Gary Nachman
| $469.31 | $298 |
37%
downside
| Outperform |
1 Nov ‘24
10 months ago |
|
503 |
503
Ibotta
IBTA
$745M
|
AM
Andrew Marok
| $26.23 | $85 |
224%
upside
| Outperform |
29 Oct ‘24
10 months ago |
|
504 |
504
Taylor Morrison
TMHC
$6.89B
|
BH
Buck Horne
| $69.69 | $84 |
21%
upside
| Outperform |
29 Oct ‘24
10 months ago |
|
505 |
505
ProQR Therapeutics
PRQR
$237M
|
SS
Steven Seedhouse
| $2.25 | $14 |
522%
upside
| Strong Buy |
29 Oct ‘24
10 months ago |
|
506 |
506
Harmonic Inc
HLIT
$1.12B
|
SL
Simon Leopold
| $9.84 | $14 |
42%
upside
| Outperform |
29 Oct ‘24
10 months ago |
|
507 |
507
Community Bank
CBU
$3.13B
|
SM
Steve Moss
| $59.14 | $67 |
13%
upside
| Strong Buy |
28 Oct ‘24
10 months ago |
|
508 |
508
Patterson-UTI
PTEN
$2.11B
|
JR
James Rollyson
| $5.47 | $11 |
101%
upside
| Strong Buy |
25 Oct ‘24
10 months ago |
|
509 |
509
PROG Holdings
PRG
$1.39B
|
BG
Bobby Griffin
| $35.05 | $48 |
37%
upside
| Outperform |
24 Oct ‘24
10 months ago |
|
510 |
KREF
510
KKR Real Estate Finance Trust
KREF
$644M
|
SL
Stephen Laws
| $9.80 | $13.50 |
38%
upside
| Outperform |
23 Oct ‘24
10 months ago |
|
511 |
511
Enphase Energy
ENPH
$4.85B
|
PM
Pavel Molchanov
| $37.12 | $130 |
250%
upside
| Outperform |
23 Oct ‘24
10 months ago |
|
512 |
512
SmartFinancial
SMBK
$627M
|
MR
Michael Rose
| $36.86 | $36 |
2%
downside
| Strong Buy |
23 Oct ‘24
10 months ago |
|
513 |
513
Banc of California
BANC
$2.65B
|
MR
Michael Rose
| $16.82 | $17 |
1%
upside
| Outperform |
23 Oct ‘24
10 months ago |
|
514 |
514
Home Bancorp
HBCP
$437M
|
WW
William Wallace
| $55.82 | $50 |
10%
downside
| Outperform |
21 Oct ‘24
10 months ago |
|
515 |
515
Wave Life Sciences
WVE
$1.18B
|
SS
Steven Seedhouse
| $7.39 | $22 |
198%
upside
| Strong Buy |
16 Oct ‘24
10 months ago |
|
516 |
516
Globe Life
GL
$11.3B
|
WB
Wilma Burdis
| $139.02 | $188 |
35%
upside
| Strong Buy |
15 Oct ‘24
11 months ago |
|
517 |
517
Intercontinental Exchange
ICE
$98.6B
|
PO
Patrick O'Shaughnessy
| $172.23 | $185 |
7%
upside
| Outperform |
14 Oct ‘24
11 months ago |
|
518 |
PAL
518
Proficient Auto Logistics
PAL
$207M
|
PTB
Patrick Tyler Brown
| $7.45 | $19 |
155%
upside
| Outperform |
14 Oct ‘24
11 months ago |
|
519 |
519
BioMarin Pharmaceuticals
BMRN
$10.5B
|
DB
Danielle Brill
| $54.50 | $79 |
45%
upside
| Outperform |
10 Oct ‘24
11 months ago |
|
520 |
520
Regenxbio
RGNX
$483M
|
DB
Danielle Brill
| $9.57 | $18 |
88%
upside
| Outperform |
10 Oct ‘24
11 months ago |
|
521 |
521
Neurocrine Biosciences
NBIX
$14B
|
DB
Danielle Brill
| $141.25 | $155 |
10%
upside
| Outperform |
10 Oct ‘24
11 months ago |
|
522 |
522
Immunovant
IMVT
$2.82B
|
DB
Danielle Brill
| $16.20 | $36 |
122%
upside
| Outperform |
10 Oct ‘24
11 months ago |
|
523 |
523
Harmony Biosciences
HRMY
$1.91B
|
DB
Danielle Brill
| $33.21 | $40 |
20%
upside
| Outperform |
10 Oct ‘24
11 months ago |
|
524 |
524
Sarepta Therapeutics
SRPT
$1.8B
|
DB
Danielle Brill
| $17.22 | $150 |
771%
upside
| Outperform |
10 Oct ‘24
11 months ago |
|
525 |
525
argenx
ARGX
$46.7B
|
DB
Danielle Brill
| $762.89 | $605 |
21%
downside
| Strong Buy |
10 Oct ‘24
11 months ago |
|